These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 37651917)
1. Comparison of three Dos Santos SN; Wuest M; Jans HS; Woodfield J; Nario AP; Krys D; Dufour J; Glubrecht D; Bergman C; Bernardes ES; Wuest F Nucl Med Biol; 2023; 124-125():108383. PubMed ID: 37651917 [TBL] [Abstract][Full Text] [Related]
2. Synthesis of a 2-nitroimidazole derivative N-(4-[ Nario AP; Woodfield J; Dos Santos SN; Bergman C; Wuest M; Araújo YB; Lapolli AL; West FG; Wuest F; Bernardes ES EJNMMI Radiopharm Chem; 2022 Jun; 7(1):13. PubMed ID: 35697954 [TBL] [Abstract][Full Text] [Related]
3. In Vivo Ester Hydrolysis as a New Approach in Development of Positron Emission Tomography Tracers for Imaging Hypoxia. Zhang L; Yao X; Cao J; Hong H; Zhang A; Zhao R; Zhang Y; Zha Z; Liu Y; Qiao J; Zhu L; Kung HF Mol Pharm; 2019 Mar; 16(3):1156-1166. PubMed ID: 30676751 [TBL] [Abstract][Full Text] [Related]
4. Positron Emission Tomography (PET) and Pharmacokinetics: Classical Blood Sampling Versus Image-Derived Analysis of [18F]FAZA and [18F]FDG in a Murine Tumor Bearing Model. Jans HS; Yang XH; Brocks DR; Kumar P; Wuest M; Wiebe LI J Pharm Pharm Sci; 2018; 21(1s):32s-47s. PubMed ID: 29702045 [TBL] [Abstract][Full Text] [Related]
5. Imaging of tumor hypoxia with [124I]IAZA in comparison with [18F]FMISO and [18F]FAZA--first small animal PET results. Reischl G; Dorow DS; Cullinane C; Katsifis A; Roselt P; Binns D; Hicks RJ J Pharm Pharm Sci; 2007; 10(2):203-11. PubMed ID: 17706178 [TBL] [Abstract][Full Text] [Related]
13. [18F]Fluoroazomycinarabinofuranoside (18FAZA) and [18F]Fluoromisonidazole (18FMISO): a comparative study of their selective uptake in hypoxic cells and PET imaging in experimental rat tumors. Sorger D; Patt M; Kumar P; Wiebe LI; Barthel H; Seese A; Dannenberg C; Tannapfel A; Kluge R; Sabri O Nucl Med Biol; 2003 Apr; 30(3):317-26. PubMed ID: 12745023 [TBL] [Abstract][Full Text] [Related]
14. Correlation of [18F]FMISO autoradiography and pimonidazole [corrected] immunohistochemistry in human head and neck carcinoma xenografts. Troost EG; Laverman P; Philippens ME; Lok J; van der Kogel AJ; Oyen WJ; Boerman OC; Kaanders JH; Bussink J Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1803-11. PubMed ID: 18421457 [TBL] [Abstract][Full Text] [Related]
15. Comparison of 18F-fluoroazomycin-arabinofuranoside and 64Cu-diacetyl-bis(N4-methylthiosemicarbazone) in preclinical models of cancer. Valtorta S; Belloli S; Sanvito F; Masiello V; Di Grigoli G; Monterisi C; Fazio F; Picchio M; Moresco RM J Nucl Med; 2013 Jul; 54(7):1106-12. PubMed ID: 23699667 [TBL] [Abstract][Full Text] [Related]
17. Comparison of [18F]-FMISO, [18F]-FAZA and [18F]-HX4 for PET imaging of hypoxia--a simulation study. Wack LJ; Mönnich D; van Elmpt W; Zegers CM; Troost EG; Zips D; Thorwarth D Acta Oncol; 2015; 54(9):1370-7. PubMed ID: 26203928 [TBL] [Abstract][Full Text] [Related]
18. Synthesis and Bioevaluation of Novel [ Yang X; Wang F; Zhu H; Yang Z; Chu T Mol Pharm; 2019 May; 16(5):2118-2128. PubMed ID: 30964298 [TBL] [Abstract][Full Text] [Related]
19. Kinetic Evaluation of the Hypoxia Radiotracers [ Choen S; Kent MS; Chaudhari AJ; Cherry SR; Krtolica A; Zwingenberger AL Nucl Med Mol Imaging; 2023 Feb; 57(1):16-25. PubMed ID: 36643946 [TBL] [Abstract][Full Text] [Related]
20. A comparison of the imaging characteristics and microregional distribution of 4 hypoxia PET tracers. Carlin S; Zhang H; Reese M; Ramos NN; Chen Q; Ricketts SA J Nucl Med; 2014 Mar; 55(3):515-21. PubMed ID: 24491409 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]